Pfizer May File for Emergency Authorization of Coronavirus Vaccine Within the Week
Pfizer (NYSE: PFE) may be about to take a major step forward in its coronavirus vaccine development efforts.
"We are very close to submitting for an emergency use authorization," CEO Albert Bourla said during the STAT Summit on Tuesday.
An emergency use authorization (EUA) is not the same as full-scale regulatory approval, but if Pfizer is granted an EUA, the U.S Food and Drug Administration could authorize the use of the drugmaker's experimental vaccine during the COVID-19 crisis.
Source Fool.com
